Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Summer, Ross

< Back


Ross Summer, MD

Ross Summer, MD

Contact Dr. Summer

834 Walnut Street
Suite 650
Philadelphia, PA 19107

(215) 955-5161
(215) 955-0830 fax

Medical School

Louisiana State University - New Orleans - 1996


Johns Hopkins University Hospital


Boston University Medical Center Hospital

Board Certification

Critical Care Medicine
Pulmonary Disease
Internal Medicine

Hospital Appointment

Thomas Jefferson University Hospital

University Appointment

Professor of Medicine

Research & Clinical Interests

Dr Ross Summer is a board certified pulmonary and critical care physician and an NIH-funded investigator. Dr Summer completed his residency training in Internal Medicine at Johns Hopkins Hospital in Baltimore, Maryland and then went on to complete a four-year pulmonary and critical care fellowship at Boston University. Dr Summer spends his time attending on the pulmonary consult service and in the medical intensive care unit at Thomas Jefferson in center city Philadelphia. In addition, Dr Summer spends a significant portion of his time overseeing a basic science program whose major focus is to understand the molecular mechanisms contributing to the pathogenesis of Acute Respiratory Distress syndrome (ARDS) and Idiopathic Pulmonary Fibrosis (IPF).


Most Recent Peer-Reviewed Publications

  1. Severe airflow obstruction in a man with stomatitis and lymphadenopathy
  2. Muc1 deficiency exacerbates pulmonary fibrosis in a mouse model of silicosis
  3. Protein folding and the challenges of maintaining endoplasmic reticulum proteostasis in idiopathic pulmonary fibrosis
  4. Target-Specific Delivery of an Antibody That Blocks the Formation of Collagen Deposits in Skin and Lung
  5. Obesity-induced endoplasmic reticulum stress causes lung endothelial dysfunction and promotes acute lung injury
  6. An official American thoracic society workshop report: Obesity and metabolism an emerging frontier in lung health and disease
  7. Binding of CIB1 to the aIIb tail of aIIbβ3 is required for FAK recruitment and activation in platelets
  8. T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity
  9. Chronic Obstructive Pulmonary Disease
  10. Surfactant lipids at the host-environment interface metabolic sensors, suppressors, and effectors of inflammatory lung disease
  11. Pulmonary alveolar proteinosis: Pathogenesis, diagnosis, and management
  12. Therapeutic advances in idiopathic pulmonary fibrosis
  13. C1q deficiency promotes pulmonary vascular inflammation and enhances the susceptibility of the lung endothelium to injury
  14. Systemic Inflammatory Response Syndrome Criteria for Severe Sepsis
  15. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis
  16. Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury
  17. Direct effects of leptin and adiponectin on peripheral reproductive tissues: A critical review
  18. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension
  19. To the editor
  20. IL-15Rα is a determinant of muscle fuel utilization, and its loss protects against obesity